Australia's largest stock trading and investment forum Australia's #1 stock forum

COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-95234

First 95234 Last

Share
Profile

Follow
Ciao!

7,156 Posts.

53

02/05/24

07:58

Post #: 73620732
Share

Originally posted by logco: ↑

Data from AstraZeneca’s clinical trials, involving 24,000 people, found four of these thromboembolic events occurred in people given the vaccine, and eight occurred in the placebo group who didn’t receive the COVID vaccine.
Following vaccination with the AstraZeneca shot, these events did not occur at a rate higher than the expected “background rate”.
As of March 10, there have been30 thromboembolic eventsreported from almost five million people given COVID vaccines in the European Economic Area.
In the UK, more than 11 million doses of the AstraZeneca vaccine have been administered, and the rate of blood clots hasnot been greater than the natural rate expected to occur.
Australia will need to detect whether rates of clots are the same or greater than expected following COVID vaccines. To do so, our vaccine safety surveillance service in Victoria, called SAEFVIC, has determined local background rates of these (and other) potential adverse events, though this isn’t yet published data. Other jurisdictions throughout Australia have done the same, in collaboration with the TGA. As the COVID vaccine rollout continues, we will monitor if the number of these events in Australia remains within the expected “background rate”.

Data suggest no increased risk of blood clots from the AstraZeneca vaccine. Australia shouldn’t pause its rollout (theconversation.com)

Expand

So, why was the AstraZenica vaccine withdrawn?
4 Upvote

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

There are more pages in this discussion • 6,610 more messages in this thread...

First 95234 Last

COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-95234

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

Featured News

Featured News

COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-95234

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

Featured News

Featured News